Mohit Manrao, SVP, Head of US Oncology at AstraZeneca, shared a post on LinkedIn:
“AstraZeneca rings opening bell at the New York Stock Exchange.
Today’s NYSE opening bell ringing marks an important milestone for AstraZeneca in the US.
It reflects the momentum behind our science, the strength of our pipeline and our continued investment in innovation to help bring new medicines to patients.
In oncology, that momentum is especially important as science continues to reshape what is possible in cancer care.
Thank you to everyone who made today possible, and to colleagues across AstraZeneca whose commitment and passion continue to demonstrate What Science Can Do.”
Other articles featuring Mohit Manrao on OncoDaily.